group-telegram.com/theBRAINet/309
Last Update:
π§ Neurofibromatosis type 2
π Neurofibromatosis type 2 is an autosomal-dominant multiple neoplasia syndrome that results from mutations in the NF2 tumour suppressor gene located on chromosome 22q.
π It has a frequency of one in 25,000 livebirths and nearly 100% penetrance by 60 years of age.
π Half of patients inherit a germline mutation from an affected parent and the remainder acquire a de novo mutation for neurofibromatosis type 2.
π Patients develop nervous system tumours (schwannomas, meningiomas, ependymomas, astrocytomas, and neurofibromas), peripheral neuropathy, ophthalmological lesions (cataracts, epiretinal membranes, and retinal hamartomas), and cutaneous lesions (skin tumours).
πSource:
- Neurosurgery Board Review, Third Edition
- Neurofibromatosis type 2: A Review study
#MCQ #Neuroradiology
βββββββββββββ
π Join us in BRAINet
βοΈ Telegram: @theBRAINet
βοΈ Instagram: @theBRAINet
βοΈ Email: brainet.neuroscience@gmail.com
βοΈ Website: theBRAINet.org
BY BRAINet

Share with your friend now:
group-telegram.com/theBRAINet/309